192 results
Page 3 of 10
8-K
EX-4.1
rwiglz
31 Jul 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market
8:28am
424B5
7d8cw7tm2d
31 Jul 23
Prospectus supplement for primary offering
8:23am
8-K
EX-99.1
gyejts1ptyhy5rtwq8zb
27 Jul 23
55% objective response rate; 23% complete response rate in locally advanced cSCC
7:30am
8-K
EX-10.1
t6ex8be
13 Jun 23
Departure of Directors or Certain Officers
7:00am
8-K
5exkqcs9fk dz9p4djly
13 Jun 23
Departure of Directors or Certain Officers
7:00am
424B5
8ssxkc 06326w
24 May 23
Prospectus supplement for primary offering
5:25pm
8-K
EX-10.1
xr7w3r8h
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
8-K
EX-5.1
cliche
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
8-K
EX-4.1
710vaa n8j
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
8-K
EX-4.3
iy7a0e5 pif
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
8-K
EX-4.2
glx89x
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
8-K
EX-10.1
dcxa7x
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
8-K
EX-4.2
r2lj2qzl2fqh5iu
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am